A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone

Author： Mason B.J.   Goodman A.M.   Dixon R.M.   Hameed M.H.A.   Hulot T.   Wesnes K.   Hunter J.A.   Boyeson M.G.  

Publisher： Elsevier

ISSN： 0893-133X

Source： Neuropsychopharmacology, Vol.27, Iss.4, 2002-10, pp. : 596-606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acamprosate, naltrexone underused in Australia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram

By Brosen K.   Naranjo C.A.  

European Neuropsychopharmacology, Vol. 11, Iss. 4, 2001-08 ,pp. : 275-283

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Variability: A Daunting Challenge in Drug Therapy

By  

Current Drug Metabolism, Vol. 8, Iss. 2, 2007-02 ,pp. : 109-136

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

By Yang Bing-Bing   Lum Peggy   Chen Alin   Arends Rosalin   Roskos Lorin   Smith Brian   Ruixo Juan José Pérez  

Clinical Pharmacokinetics, Vol. 49, Iss. 11, 2010-11 ,pp. : 729-740

Adis International

Access to resources Recommend Favorite

Role of Mechanistically-Based Pharmacokinetic/Pharmacodynamic Models in Drug Development: A Case Study of a Therapeutic Protein

By Marshall Scott  

Clinical Pharmacokinetics, Vol. 45, Iss. 2, 2006-01 ,pp. : 177-197

Adis International

Access to resources Recommend Favorite